Literature DB >> 34709729

Olfaction before and after initiation of elexacaftor-tezacaftor-ivacaftor in a cystic fibrosis cohort.

Daniel R Bacon1, Amanda Stapleton2, Jennifer L Goralski3, Charles S Ebert1, Brian D Thorp1, Mehdi Nouraie4, Amber D Shaffer2, Brent A Senior1, Stella E Lee2, Anna C Zemke4, Adam J Kimple1.   

Abstract

Entities:  

Keywords:  olfaction; olfactory disorders; olfactory test

Mesh：

Substances：

Year:  2021        PMID： 34709729      PMCID： PMC8792160          DOI： 10.1002/alr.22891

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN： 2042-6976            Impact factor:   3.858


× No keyword cloud information.
  9 in total

1.  Olfactory dysfunction in patients with head trauma.

Authors:  R L Doty; D M Yousem; L T Pham; A A Kreshak; R Geckle; W W Lee
Journal:  Arch Neurol       Date:  1997-09

2.  Chemosensory function and food preferences of children with cystic fibrosis.

Authors:  David G Laing; Jessica E Armstrong; Maggie Aitken; Alistair Carroll; Fiona J Wilkes; Anthony L Jinks; Adam Jaffé
Journal:  Pediatr Pulmonol       Date:  2010-08

3.  Smell in cystic fibrosis.

Authors:  J Lindig; C Steger; N Beiersdorf; R Michl; J F Beck; T Hummel; J G Mainz
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-14       Impact factor: 2.503

4.  Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function.

Authors:  R L Doty; P Shaman; M Dann
Journal:  Physiol Behav       Date:  1984-03

5.  Effect of highly effective modulator therapy on quality of life in adults with cystic fibrosis.

Authors:  Emily DiMango; Daniel B Spielman; Jonathan Overdevest; Claire Keating; Sarah Fracasso Francis; David Dansky; David A Gudis
Journal:  Int Forum Allergy Rhinol       Date:  2020-09-28       Impact factor: 3.858

6.  The influence of olfactory loss on dietary behaviors.

Authors:  Katja Aschenbrenner; Cornelia Hummel; Katja Teszmer; Franziska Krone; Tadashi Ishimaru; Han-Seok Seo; Thomas Hummel
Journal:  Laryngoscope       Date:  2008-01       Impact factor: 3.325

7.  VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.

Authors:  Dominic Keating; Gautham Marigowda; Lucy Burr; Cori Daines; Marcus A Mall; Edward F McKone; Bonnie W Ramsey; Steven M Rowe; Laura A Sass; Elizabeth Tullis; Charlotte M McKee; Samuel M Moskowitz; Sarah Robertson; Jessica Savage; Christopher Simard; Fredrick Van Goor; David Waltz; Fengjuan Xuan; Tim Young; Jennifer L Taylor-Cousar
Journal:  N Engl J Med       Date:  2018-10-18       Impact factor: 91.245

8.  Olfactory epithelia exhibit progressive functional and morphological defects in CF mice.

Authors:  Barbara R Grubb; Troy D Rogers; Heather M Kulaga; Kimberlie A Burns; Robert L Wonsetler; Randall R Reed; Lawrence E Ostrowski
Journal:  Am J Physiol Cell Physiol       Date:  2007-04-11       Impact factor: 4.249

Review 9.  Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist.

Authors:  Saangyoung E Lee; Zainab Farzal; M Leigh Anne Daniels; Brian D Thorp; Adam M Zanation; Brent A Senior; Charles S Ebert; Adam J Kimple
Journal:  Am J Rhinol Allergy       Date:  2020-03-13       Impact factor: 2.467
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.